Search
for
Sort by
Research 30 of 260
- Azithromycin and Roxithromycin define a new family of “senolytic” drugs that target senescent human fibroblasts
- Combination of Low-Dose Isotretinoin and Pulsed Oral Azithromycin in the Management of Moderate to Severe Acne
- Azithromycin with nitazoxanide, hydroxychloroquine or ivermectin, with or without dutasteride, for early stage COVID-19: an open-label prospective observational study in males with mild-to-moderate COVID-19 (The Pre-AndroCoV Male Trial).
- Azithromycin with nitazoxanide, hydroxychloroquine or ivermectin, with or without dutasteride, for early stage COVID-19: an open-label prospective observational study in males with mild-to-moderate COVID-19 (The Pre-AndroCoV Male Trial).
- Early COVID-19 Therapy with Azithromycin Plus Nitazoxanide, Ivermectin or Hydroxychloroquine in Outpatient Settings Significantly Reduced Symptoms Compared to Known Outcomes in Untreated Patients.
- Early COVID-19 Therapy with Azithromycin Plus Nitazoxanide, Ivermectin or Hydroxychloroquine in Outpatient Settings Significantly Reduced Symptoms Compared to Known Outcomes in Untreated Patients
- An Underrecognized Adverse Effect of Azithromycin
- Acute generalized exanthematous pustulosis induced by hydroxychloroquine prescribed for COVID-19
- An open-label prospective observational study of antiandrogen and non-antiandrogen early pharmacological approaches in females with mild-to-moderate COVID-19. The Pre-AndroCoV Female Trial
- Hydroxychloroquine, nitazoxanide and ivermectin have similar effects in early COVID-19: a head-to-head comparison of the Pre-AndroCoV Trial.
- Confluent and Reticulated Papillomatosis Associated with Polycystic Ovarian Syndrome
- Case Report: Multiple Scalp Abscesses due to Mycobacterium abscessus Infection Following Triamcinolone Injection in an Immunocompetent Person
- Post Covid telogen effluvium: the diagnostic value of serum ferritin biomarker and the preventive value of dietary supplements. a case control study
- CARACTERÍSTICAS CLÍNICAS E EPIDEMIOLÓGICAS DO EFLÚVIO TELÓGENO PÓS COVID-19
- Referee report. For: Comparison between Tazarotene 0.05% gel and Adapelene 0.1% gel in acne patients [version 1; peer review: 1 approved with reservations]
- Dermatolojik Problemler ve COVID-19
- Differentiation of HaCaT skin cells in culture and their potential for studying atopic dermatitis
- Covid-19 in Lupus Nephritis
- Covid-19 in Lupus Nephritis
- Mechanism of Targeting the Hedgehog Signaling Pathway against Chemotherapeutic Resistance in Multiple Myeloma
- A case of rosacea fulminans during pregnancy with review of the literature
- Updates in therapeutics for folliculitis decalvans: A systematic review with evidence-based analysis
- COVID-19-Related Neuropathic Pain: A Systematic Review and Meta-Analysis
- The Advances of Broad-Spectrum and Hot Anti-Coronavirus Drugs
- An 85-Year-Old Man With Recurrent Fever and Multiple Splenic Infarcts
- Black dots in trichoscopy after COVID‐19. Can it be telogen effluvium?
- Contact Allergic Dermatitis to Quinine in an Anti-hair Loss Lotion
- A review of diagnosis and treatment of acne in adult female patients
- New onset of alopecia areata in a patient with SARS‐CoV‐2 infection: Possible pathogenetic correlations?
- Keratosis follicularis spinulosa decalvans in a female